Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
β Scribed by Jing-Houng Wang; Chih-Chi Wang; Chao-Hung Hung; Chao-Long Chen; Sheng-Nan Lu
- Book ID
- 116652522
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 573 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Radiofrequency ablation (RFA) is becoming a wellβknown local therapy for hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization (TACE) is expected to enhance the effects of subsequent RFA by reducing arterial blood flow. However, the longβterm efficacy
No adequate randomized trials have been reported for a comparison between hepatic resection (HR) versus radiofrequency ablation (RFA) for the treatment of patients with very early stage hepatocellular carcinoma (HCC), defined as an asymptomatic solitary HCC <2 cm. For compensated cirrhotic patients